Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy

Met is a receptor tyrosine kinase that promotes cancer progression. In addition, Met has been implicated in resistance of tumors to various targeted therapies such as EGFR inhibitors in lung cancers, and has been prioritized as a key molecular target for cancer therapy. However, the underlying mecha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncogene
Egile Nagusiak: Kim, Bogyou, Wang, Shangzi, Lee, Ji Min, Jeong, Yunju, Ahn, TaeJin, Son, Dae-Soon, Park, Hye Won, Yoo, Hyeon-seok, Song, Yun-Jeong, Lee, Eunjin, Oh, Young Mi, Lee, Saet Byoul, Choi, Jaehyun, Murray, Joseph C, Zhou, Yan, Song, Paul H, Kim, Kyung-Ah, Weiner, Louis M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4300291/
https://ncbi.nlm.nih.gov/pubmed/24662823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2014.51
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak